# FDA Inspection 1010222 - HEMOGENYX LLC - May 04, 2017

Source: https://www.keypedia.com/records/fda_inspections/hemogenyx-llc/647cf9b0-3938-4322-9a9f-4489a836d2eb
Source feed: FDA_Inspections

> FDA Inspection 1010222 for HEMOGENYX LLC on May 04, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010222
- Company Name: HEMOGENYX LLC
- Inspection Date: 2017-05-04
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

Company: https://www.keypedia.com/companies/hemogenyx-llc/6645c4cf-d5c8-422b-b4a5-4eb5d8a27566

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d